<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35503798</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1553-7374</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>PLoS pathogens</Title>
          <ISOAbbreviation>PLoS Pathog</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Influenza A virus NS1 protein hijacks YAP/TAZ to suppress TLR3-mediated innate immune response.</ArticleTitle>
        <Pagination>
          <StartPage>e1010505</StartPage>
          <MedlinePgn>e1010505</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e1010505</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1010505</ELocationID>
        <Abstract>
          <AbstractText>The Hippo signaling pathway, which is historically considered as a dominator of organ development and homeostasis has recently been implicated as an immune regulator. However, its role in host defense against influenza A virus (IAV) has not been widely investigated. Here, we found that IAV could activate the Hippo effectors Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) through physical binding of the IAV non-structural protein 1 (NS1) with C-terminal domain of YAP/TAZ, facilitating their nuclear location. Meanwhile, YAP/TAZ downregulated the expression of pro-inflammatory and anti-viral cytokines against IAV infection, therefore benefiting virus replication and host cell apoptosis. A mouse model of IAV infection further demonstrated Yap deficiency protected mice against IAV infection, relieving lung injury. Mechanistically, YAP/TAZ blocked anti-viral innate immune signaling via downregulation of Toll-like receptor 3 (TLR3) expression. YAP directly bound to the putative TEADs binding site on the promoter region of TLR3. The elimination of acetylated histone H3 occupancy in the TLR3 promoter resulted in its transcriptional silence. Moreover, treatment of Trichostatin A, a histone deacetylases (HDACs) inhibitor or disruption of HDAC4/6 reversed the inhibition of TLR3 expression by YAP/TAZ, suggesting HDAC4/6 mediated the suppression function of YAP/TAZ. Taken together, we uncovered a novel immunomodulatory mechanism employed by IAV, where YAP/TAZ antagonize TLR3-mediated innate immunity.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Qiong</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Xujun</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lei</LastName>
            <ForeName>Xiaobo</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">0000-0002-3455-6723</Identifier>
            <AffiliationInfo>
              <Affiliation>NHC Key Laboratory of System Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Hai</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Jingjing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yuchong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bi</LastName>
            <ForeName>Kefan</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Diao</LastName>
            <ForeName>Hongyan</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0002-7197-4051</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS Pathog</MedlineTA>
        <NlmUniqueID>101238921</NlmUniqueID>
        <ISSNLinking>1553-7366</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C519703">TLR3 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009980" MajorTopicYN="Y">Influenza A virus</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051196" MajorTopicYN="Y">Toll-Like Receptor 3</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>13</Hour>
          <Minute>35</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35503798</ArticleId>
        <ArticleId IdType="pmc">PMC9122210</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.ppat.1010505</ArticleId>
        <ArticleId IdType="pii">PPATHOGENS-D-21-02312</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al.. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25: 5086–5096. doi: 10.1016/j.vaccine.2007.03.046
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2007.03.046</ArticleId>
            <ArticleId IdType="pubmed">17544181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potter CW. A history of influenza. J Appl Microbiol. 2001;91: 572–579. doi: 10.1046/j.1365-2672.2001.01492.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2672.2001.01492.x</ArticleId>
            <ArticleId IdType="pubmed">11576290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng VC, To KK, Tse H, Hung IF, Yuen KY. Two years after pandemic influenza A/2009/H1N1: what have we learned?. Clin Microbiol Rev. 2012;25: 223–263. doi: 10.1128/CMR.05012-11
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.05012-11</ArticleId>
            <ArticleId IdType="pmc">PMC3346300</ArticleId>
            <ArticleId IdType="pubmed">22491771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol. 2014;14: 315–328. doi: 10.1038/nri3665
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri3665</ArticleId>
            <ArticleId IdType="pmc">PMC4104278</ArticleId>
            <ArticleId IdType="pubmed">24762827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, Bier K, et al.. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell. 2010;140: 397–408. doi: 10.1016/j.cell.2010.01.020
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2010.01.020</ArticleId>
            <ArticleId IdType="pubmed">20144762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, et al.. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates. Science. 2006;314: 997–1001. doi: 10.1126/science.1132998
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1132998</ArticleId>
            <ArticleId IdType="pubmed">17038589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, et al.. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009;30: 556–565. doi: 10.1016/j.immuni.2009.02.005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2009.02.005</ArticleId>
            <ArticleId IdType="pmc">PMC2803103</ArticleId>
            <ArticleId IdType="pubmed">19362020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, et al.. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem. 2005;280: 5571–5580. doi: 10.1074/jbc.M410592200
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M410592200</ArticleId>
            <ArticleId IdType="pubmed">15579900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, et al.. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A. 2004;101: 5598–5603. doi: 10.1073/pnas.0400937101
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0400937101</ArticleId>
            <ArticleId IdType="pmc">PMC397437</ArticleId>
            <ArticleId IdType="pubmed">15034168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, et al.. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol. 2005;6: 981–988. doi: 10.1038/ni1243
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni1243</ArticleId>
            <ArticleId IdType="pubmed">16127453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, et al.. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 2005;437: 1167–1172. doi: 10.1038/nature04193
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature04193</ArticleId>
            <ArticleId IdType="pubmed">16177806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11: 373–384. doi: 10.1038/ni.1863
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.1863</ArticleId>
            <ArticleId IdType="pubmed">20404851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marchant D, Singhera GK, Utokaparch S, Hackett TL, Boyd JH, Luo Z, et al.. Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism. J Virol. 2010;84: 11359–11373. doi: 10.1128/JVI.00804-10
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.00804-10</ArticleId>
            <ArticleId IdType="pmc">PMC2953195</ArticleId>
            <ArticleId IdType="pubmed">20702616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jahan AS, Biquand E, Muñoz-Moreno R, Le Quang A, Mok CK, Wong HH, et al.. OTUB1 Is a Key Regulator of RIG-I-Dependent Immune Signaling and Is Targeted for Proteasomal Degradation by Influenza A NS1. Cell Rep. 2020;30: 1570–1584 e1576. doi: 10.1016/j.celrep.2020.01.015
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2020.01.015</ArticleId>
            <ArticleId IdType="pubmed">32023470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, et al.. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009;5: 439–449. doi: 10.1016/j.chom.2009.04.006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chom.2009.04.006</ArticleId>
            <ArticleId IdType="pmc">PMC2737813</ArticleId>
            <ArticleId IdType="pubmed">19454348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koliopoulos MG, Lethier M, van der Veen AG, Haubrich K, Hennig J, Kowalinski E, et al.. Molecular mechanism of influenza A NS1-mediated TRIM25 recognition and inhibition. Nat Commun. 2018;9: 1820. doi: 10.1038/s41467-018-04214-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-018-04214-8</ArticleId>
            <ArticleId IdType="pmc">PMC5940772</ArticleId>
            <ArticleId IdType="pubmed">29739942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villan E, et al.. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog. 2012;8: e1003059. doi: 10.1371/journal.ppat.1003059
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1003059</ArticleId>
            <ArticleId IdType="pmc">PMC3510253</ArticleId>
            <ArticleId IdType="pubmed">23209422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park HS, Liu G, Thulasi Raman SN, Landreth SL, Liu Q, Zhou Y. NS1 Protein of 2009 Pandemic Influenza A Virus Inhibits Porcine NLRP3 Inflammasome-Mediated Interleukin-1 Beta Production by Suppressing ASC Ubiquitination. J Virol. 2018;92: e00022–00018. doi: 10.1128/JVI.00022-18
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.00022-18</ArticleId>
            <ArticleId IdType="pmc">PMC5874408</ArticleId>
            <ArticleId IdType="pubmed">29386291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moriyama M, Chen IY, Kawaguchi A, Koshiba T, Nagata K, Takeyama H, et al.. The RNA- and TRIM25-Binding Domains of Influenza Virus NS1 Protein Are Essential for Suppression of NLRP3 Inflammasome-Mediated Interleukin-1beta Secretion. J Virol. 2016;90: 4105–4114. doi: 10.1128/JVI.00120-16
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.00120-16</ArticleId>
            <ArticleId IdType="pmc">PMC4810543</ArticleId>
            <ArticleId IdType="pubmed">26865721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Zhao B, Guan KL. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and
Cancer. Cell. 2015;163: 811–828.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13: 63–79. doi: 10.1038/nrd4161
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd4161</ArticleId>
            <ArticleId IdType="pmc">PMC4167640</ArticleId>
            <ArticleId IdType="pubmed">24336504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell. 2003;114: 457–467. doi: 10.1016/s0092-8674(03)00557-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0092-8674(03)00557-9</ArticleId>
            <ArticleId IdType="pubmed">12941274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol. 2003;5: 914–920. doi: 10.1038/ncb1050
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb1050</ArticleId>
            <ArticleId IdType="pubmed">14502294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kango-Singh M, Nolo R, Tao C, Verstreken P, Hiesinger PR, Bellen HJ, et al.. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development. 2002;129: 5719–5730. doi: 10.1242/dev.00168
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.00168</ArticleId>
            <ArticleId IdType="pubmed">12421711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N, et al.. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell. 2005;120: 675–685. doi: 10.1016/j.cell.2004.12.036
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2004.12.036</ArticleId>
            <ArticleId IdType="pubmed">15766530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Ren F, Zhang Q, Chen Y, Wang B, Jiang J. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell. 2008;14: 377–387. doi: 10.1016/j.devcel.2008.01.006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2008.01.006</ArticleId>
            <ArticleId IdType="pmc">PMC2292673</ArticleId>
            <ArticleId IdType="pubmed">18258485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA, Sillje HH. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 2005;24: 2076–2086. doi: 10.1038/sj.onc.1208445
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1208445</ArticleId>
            <ArticleId IdType="pubmed">15688006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al.. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21: 2747–2761. doi: 10.1101/gad.1602907
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1602907</ArticleId>
            <ArticleId IdType="pmc">PMC2045129</ArticleId>
            <ArticleId IdType="pubmed">17974916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Meng F, Chen S, Plouffe SW, Wu S, Liu S, et al.. Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade. Nat Cell Biol. 2017;19: 362–374. doi: 10.1038/ncb3496
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb3496</ArticleId>
            <ArticleId IdType="pmc">PMC5398908</ArticleId>
            <ArticleId IdType="pubmed">28346439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S, Xie F, Chu F, Zhang Z, Yang B, Dai T, et al.. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKvarepsilon-mediated phosphorylation. Nat Immunol. 2017;18: 1270.</Citation>
        </Reference>
        <Reference>
          <Citation>Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A. 2006;103: 14194–14199. doi: 10.1073/pnas.0606109103
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0606109103</ArticleId>
            <ArticleId IdType="pmc">PMC1599933</ArticleId>
            <ArticleId IdType="pubmed">16963558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dubrow A, Lin S, Savage N, Shen Q, Cho JH. Molecular Basis of the Ternary Interaction between NS1 of the 1918 Influenza A Virus, PI3K, and CRK. Viruses. 2020;12: 338.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Han X, Chen JF, Xie XM, Xu JF, Zhao Y, et al.. Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) mediate cell density-dependent proinflammatory responses. Journal of Biological Chemistry. 2018;293: 18071–18085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6254335</ArticleId>
            <ArticleId IdType="pubmed">30315101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed J, Alb JG, et al.. Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol Cell Biol. 2006;26: 77–87. doi: 10.1128/MCB.26.1.77-87.2006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.26.1.77-87.2006</ArticleId>
            <ArticleId IdType="pmc">PMC1317614</ArticleId>
            <ArticleId IdType="pubmed">16354681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Lu W, Zhang Y, Zou F, Jin Z, Zhao T. The Hippo Pathway and Viral Infections. Front Microbiol.
2019;10: 3033. doi: 10.3389/fmicb.2019.03033
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2019.03033</ArticleId>
            <ArticleId IdType="pmc">PMC6990114</ArticleId>
            <ArticleId IdType="pubmed">32038526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, et al.. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol. 2008;82: 335–345. doi: 10.1128/JVI.01080-07
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.01080-07</ArticleId>
            <ArticleId IdType="pmc">PMC2224404</ArticleId>
            <ArticleId IdType="pubmed">17942531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21: 381–395. doi: 10.1038/cr.2011.22
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cr.2011.22</ArticleId>
            <ArticleId IdType="pmc">PMC3193420</ArticleId>
            <ArticleId IdType="pubmed">21321607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem. 1990;265: 17174–17179. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2211619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vedadi M, Barsyte-Lovejoy D, Liu F, Rival-Gervier S, Allali-Hassani A, Labrie V, et al.. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol. 2011;7: 566–574. doi: 10.1038/nchembio.599
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.599</ArticleId>
            <ArticleId IdType="pmc">PMC3184254</ArticleId>
            <ArticleId IdType="pubmed">21743462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15: 73–79. doi: 10.1038/nrc3876
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc3876</ArticleId>
            <ArticleId IdType="pmc">PMC4562315</ArticleId>
            <ArticleId IdType="pubmed">25592648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Yang S, Chen X, Stauffer S, Yu F, Lele SM, et al.. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells. Mol Cell Biol. 2015;35: 1350–1362. doi: 10.1128/MCB.00102-15
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.00102-15</ArticleId>
            <ArticleId IdType="pmc">PMC4372700</ArticleId>
            <ArticleId IdType="pubmed">25645929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu Y, Zhang J, Zhang H, Zhai Y. Hepatitis B virus X protein mediates yes-associated protein 1 upregulation in hepatocellular carcinoma. Oncol Lett.
2016;12: 1971–1974. doi: 10.3892/ol.2016.4885
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ol.2016.4885</ArticleId>
            <ArticleId IdType="pmc">PMC4998520</ArticleId>
            <ArticleId IdType="pubmed">27602122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang T, Zhang J, You X, Liu Q, Du Y, Gao Y, et al.. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology. 2012;56: 2051–2059. doi: 10.1002/hep.25899
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.25899</ArticleId>
            <ArticleId IdType="pubmed">22707013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He C, Lv X, Huang C, Angeletti PC, Hua G, Dong J, et al.. A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis. Cell Rep.
2019;26: 2636–2650 e2635. doi: 10.1016/j.celrep.2019.02.004
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2019.02.004</ArticleId>
            <ArticleId IdType="pmc">PMC6812687</ArticleId>
            <ArticleId IdType="pubmed">30840887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Webb Strickland S, Brimer N, Lyons C, Vande Pol SB. Human Papillomavirus E6 interaction with cellular PDZ domain proteins modulates YAP nuclear localization. Virology. 2018;516: 127–138. doi: 10.1016/j.virol.2018.01.003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.virol.2018.01.003</ArticleId>
            <ArticleId IdType="pmc">PMC5826896</ArticleId>
            <ArticleId IdType="pubmed">29346075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiao S, Guan J, Chen M, Wang W, Li C, Wang Y, et al.. Targeting IRF3 as a YAP agonist therapy against gastric cancer. J Exp Med. 2018;215: 699–718. doi: 10.1084/jem.20171116
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20171116</ArticleId>
            <ArticleId IdType="pmc">PMC5789414</ArticleId>
            <ArticleId IdType="pubmed">29339449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, et al.. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell. 2009;139: 1255–1267. doi: 10.1016/j.cell.2009.12.018
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2009.12.018</ArticleId>
            <ArticleId IdType="pmc">PMC2892837</ArticleId>
            <ArticleId IdType="pubmed">20064372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Z, Cao M, Guo Y, Zhao L, Wang J, Jia X, et al.. Fragile X mental retardation protein stimulates ribonucleoprotein assembly of influenza A virus. Nat Commun.
2014;5: 3259. doi: 10.1038/ncomms4259
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms4259</ArticleId>
            <ArticleId IdType="pubmed">24514761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyer TA, Weiss A, Khomchuk Y, Huang K, Ogunjimi AA, Varelas X, et al.. Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep. 2013;5: 1611–1624. doi: 10.1016/j.celrep.2013.11.021
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2013.11.021</ArticleId>
            <ArticleId IdType="pubmed">24332857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim M, Kim T, Johnson RL, Lim DS. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Cell Rep. 2015;11: 270–282. doi: 10.1016/j.celrep.2015.03.015
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.03.015</ArticleId>
            <ArticleId IdType="pubmed">25843714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Y, Li D, Wang Y, Pei C, Liu S, Zhang L, et al.. Brahma regulates the Hippo pathway activity through forming complex with Yki-Sd and regulating the transcription of Crumbs. Cell Signal. 2015;27: 606–613. doi: 10.1016/j.cellsig.2014.12.002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2014.12.002</ArticleId>
            <ArticleId IdType="pubmed">25496831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyer TA, Weiss A, Khomchuk Y, Huang K, Ogunjimi AA, Varelas X, et al.. Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep. 2013;5: 1611–1624. doi: 10.1016/j.celrep.2013.11.021
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2013.11.021</ArticleId>
            <ArticleId IdType="pubmed">24332857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Minghetti PP, Blackburn WD Jr., Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts. J Rheumatol. 2000;27: 653–660. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10743803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu W, Zhang W, Duggan ES, Booth JL, Zou MH, Metcalf JP. RIG-I and TLR3 are both required for maximum interferon induction by influenza virus in human lung alveolar epithelial cells. Virology. 2015;482: 181–188. doi: 10.1016/j.virol.2015.03.048
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.virol.2015.03.048</ArticleId>
            <ArticleId IdType="pmc">PMC4461467</ArticleId>
            <ArticleId IdType="pubmed">25880109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wisskirchen C, Ludersdorfer TH, Müller DA, Moritz E, Pavlovic J. The Cellular RNA Helicase UAP56 Is Required for Prevention of Double-Stranded RNA Formation during Influenza A Virus Infection. J Virol. 2011;85: 8646–8655. doi: 10.1128/JVI.02559-10
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.02559-10</ArticleId>
            <ArticleId IdType="pmc">PMC3165823</ArticleId>
            <ArticleId IdType="pubmed">21680511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, et al.. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2006;2: e53. doi: 10.1371/journal.ppat.0020053
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.0020053</ArticleId>
            <ArticleId IdType="pmc">PMC1475659</ArticleId>
            <ArticleId IdType="pubmed">16789835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanco-Rodriguez J.
Programmed phosphorylation of histone H2AX precedes a phase of DNA double-strand break-independent synapsis in mouse meiosis. Reproduction. 2012;144: 699–712. doi: 10.1530/REP-12-0326
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/REP-12-0326</ArticleId>
            <ArticleId IdType="pubmed">23035256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, et al.. Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol. 2007;178: 3368–3372. doi: 10.4049/jimmunol.178.6.3368
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.178.6.3368</ArticleId>
            <ArticleId IdType="pubmed">17339430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato K, Ishii R, Goto E, Ishitani R, Tokunaga F, Nureki O. Structural and functional analyses of DNA-sensing and immune activation by human cGAS. PLoS One. 2013;8: e76983. doi: 10.1371/journal.pone.0076983
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0076983</ArticleId>
            <ArticleId IdType="pmc">PMC3792152</ArticleId>
            <ArticleId IdType="pubmed">24116191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenspan D, Palese P, Krystal M. Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol. 1988;62: 3020–3026. doi: 10.1128/JVI.62.8.3020-3026.1988
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.62.8.3020-3026.1988</ArticleId>
            <ArticleId IdType="pmc">PMC253741</ArticleId>
            <ArticleId IdType="pubmed">2969057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melén K, Kinnunen L, Fagerlund R, Ikonen N, Twu KY, Krug RM, et al.. Nuclear and Nucleolar Targeting of Influenza A Virus NS1 Protein: Striking Differences between Different Virus Subtypes. J Virol. 2007;81: 5995–6006. doi: 10.1128/JVI.01714-06
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.01714-06</ArticleId>
            <ArticleId IdType="pmc">PMC1900311</ArticleId>
            <ArticleId IdType="pubmed">17376915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cottey R, Rowe CA, Bender BS. Influenza virus. Curr Protoc Immunol Chapter. 2001;19: Unit 19 11. doi: 10.1002/0471142735.im1911s42
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/0471142735.im1911s42</ArticleId>
            <ArticleId IdType="pubmed">18432752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Ye X, Yu J, Li L, Li W, Li S, et al.. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008;22: 1962–1971. doi: 10.1101/gad.1664408
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1664408</ArticleId>
            <ArticleId IdType="pmc">PMC2492741</ArticleId>
            <ArticleId IdType="pubmed">18579750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al.. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474: 179–183. doi: 10.1038/nature10137
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10137</ArticleId>
            <ArticleId IdType="pubmed">21654799</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
